Janux Therapeutics Inc (JANX)
48.70
+2.20
(+4.73%)
USD |
NASDAQ |
Nov 22, 13:55
Janux Therapeutics Profit Margin (Quarterly): -6.39K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -6.39K% |
| June 30, 2024 | -66.98% |
| March 31, 2024 | -1.18K% |
| December 31, 2023 | -477.8% |
| September 30, 2023 | -459.6% |
| June 30, 2023 | -1.66K% |
| March 31, 2023 | -852.5% |
| December 31, 2022 | -564.7% |
| Date | Value |
|---|---|
| September 30, 2022 | -920.9% |
| June 30, 2022 | -714.1% |
| March 31, 2022 | -843.9% |
| December 31, 2021 | -830.2% |
| September 30, 2021 | -928.9% |
| June 30, 2021 | -1.29K% |
| March 31, 2021 | -601.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.39K%
Minimum
Sep 2024
-66.98%
Maximum
Jun 2024
-1.19K%
Average
-843.9%
Median
Mar 2022
Profit Margin (Quarterly) Benchmarks
| Dynavax Technologies Corp | 21.82% |
| Krystal Biotech Inc | 32.42% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -11.37% |
| Return on Assets | -10.65% |
| Return on Invested Capital | -11.37% |
| Operating Margin (Quarterly) | -8.16K% |
| Return on Net Operating Assets | -183.2% |